The effects of age and comorbidity on treatment and outcomes in women with endometrial cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 28, Issue 2, 2005, Pages 157-164

  Truong, Pauline T ^a,b   Kader, Hosam A ^a,b   Lacy, Barbara ^c   Lesperance, Mary ^c   MacNeil, Mary V ^a,c   Berthelet, Eric ^a,c   McMurtrie, Elissa ^a   Alexander, Skaria ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF VICTORIA   (Canada)

Author keywords

Age; Comorbidity; Endometrial cancer; Radiotherapy

Indexed keywords

ADULT; AGE; AGED; AGING; ARTICLE; CANADA; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHARLSON COMORBIDITY SCORE; COHORT ANALYSIS; COMORBIDITY; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PATIENT REFERRAL; PELVIS CANCER; POPULATION RESEARCH; POSTOPERATIVE CARE; PREDICTION; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; VAGINA CANCER;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 17044418867     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000143049.05090.12     Document Type: Article

References (47)

1. Canadian Cancer Statistics 2003. Toronto: National Cancer Institute of Canada; 2003.
2. Holes JL, Wu XC, McLaughlin CC, et al. Cancer in North America, 1996-2000, vol 1: incidence. Springfield, IL: North American Association of Central Cancer Registries; 2003.
3. Edwards BK, Howe HL, Ries LA, et al. Annual report to the nation on the status of cancer, 1973-1999 featuring implications of age and aging on US cancer burden. Cancer. 2002;94:2766-2792.
4. Yancik R. Cancer burden in the aged. An epidemiologic and demographic overview. Cancer. 1997;80:1273-1283.
5. Guralnik JM. Assessing the impact of comorbidity in the older population. Ann Epidemiol. 1996;6:376-380.
6. Piccirillo JF, Feinstein AR. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer. 1996;77:834-842.
7. Extermann M, Overcash J, Lyman GH, et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998;16:1582-1587.
8. Yancik R, Cumberlin R. Research recommendations for radiation therapy in older cancer patients. Int J Radiat Oncol Biol Phys. 1999;43:3-5.
9. Charlson ME, Pompei M, Ales KL, et al. A new method of classifying comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373-383.
10. Deyo RA, Gherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with 1CD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
11. D'Hoore W, Sicotte C, Tilquin C. Risk adjustments in outcome assessments: the Charlson comorbidity index. Methods Inf Med. 1993;32:382-387.
12. Mor V, Laliberte L, Morris JN, et al. The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer. 1984;53:2002-2007.
13. FIGO staging for corpus cancer. Br J Obstet Gynaecol. 1992;99:440.
14. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcomes in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991;40:55-65.
15. Hendrickson M, Ross J, Eifel PJ, et al. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables. Gynecol Oncol. 1982;13:373-392.
16. Nori D, Hilaris BS, Tome M, et al. Combined surgery and radiation in endometrial carcinoma: an analysis of prognostic factors. Int J Radiat Oncol Biol Phys. 1987;13:489-497.
17. Ambros RA, Kurman RJ. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer. 1992;69:1424-1431.
18. Mariani A, Webb MJ, Keeney GL, et al. Surgical stage I endometrial cancer: predictors of distant failure and death. Gynecol Oncol. 2002;87:274-280.
19. Hoffman K, Nekhlyudov L, Deligdisch L. Endometrial cancer in elderly women. Gynecol Oncol. 1995;58:198-201.
20. Bellino R, Arisic R, D'Addato, et al. Pathologic features of endometrial carcinoma in elderly women. Anticancer Res. 2001;21:3721-3724.
21. Ball HG, Elkadry EA. Endometrial cancer: current concepts and management. Surg Oncol Clin N Am. 1998;7:271-284.
22. Lanciano RM, Corn BW, Schultz DJ, et al. The justification of a surgical staging system in endometrial carcinoma. Radiother Oncol. 1993;28:189-193.
23. Trimble E, Kosary C, Park R. Lymph node sampling and survival in endometrial cancer. Gynecol Oncol. 1998;71:340-343.
24. Homesley HD, Kadar N, Barrett RJ, et al. Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma. Am J Obstet Gynecol. 1992;167:1225-1230.
25. Giannice R, Susini T, Ferrandina G, et al. Systematic pelvic and aortic lymphadenectomy in elderly gynecologic oncologic patients. Cancer. 2001;92:2562-2568.
26. Franchi M, Ghezzi F, Riva C, et al. Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. J Surg Oncol. 2001;78:232-237.
27. Corn BW, Lanciano RM, Greven KM, et al. Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer: a multivariate analysis. J Clin Oncol. 1994;12:510-515.
28. Kirschner CV, DeSerto TM, Isaacs JH. Surgical treatment of the elderly patient with gynecologic cancer. Surg Gynecol Obstet. 1990;170:379-384.
29. Lichtinger M, Averette H, Penalver M, et al. Major surgical procedures for gynecologic malignancy in elderly women. South Med J. 1986;79:1506-1510.
30. Lawton FG, Hacker NF. Surgery for invasive gynecologic cancer in the elderly female population. Obstet Gynecol. 1990;76:287-289.
31. Holub Z, Jabor A, Bartos P, et al. Laparoscopic surgery for endometrial cancer: long-term results of a multicentric study. Eur J Gynaecol Oncol. 2002;23:305-310.
32. Scribner DR Jr, Walker JL, Johnson GA, et al. Surgical management of early-stage endometrial cancer in the elderly: is laparoscopy feasible? Gynecol Oncol. 2001;83:563-568.
33. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404-1411.
34. Aalders J, Abeler V, Kolstad P, et al. Postoperative external irradiation and prognostic parameters in stage 1 endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol. 1980;56:419-427.
35. Creutzberg CL, van Putten WL, Koper PC, et al. The morbidity of treatment in patients with stage 1 endometrial cancer: results from a randomized trial. Int J Radiat Oncol Biol Phys. 2001;51:1246-1255.
36. Creutzberg CL, van Putten WL, Koper PC, et al. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol Oncol. 2003;89:201-209.
37. Straughn JM, Huh WK, Orr JW Jr, et al. Stage 1C adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiotherapy. Gynecol Oncol. 2003;89:295-300.
38. Curran WJ, Whittington R, Peters AJ, et al. Vaginal recurrences of endometrial carcinoma: the prognostic value of staging by primary vaginal carcinoma system. Int J Radiat Oncol Biol Phys. 1988;15:803-808.
39. Poulsen MG, Roberts SJ. The salvage of recurrence endometrial carcinoma in the vagina and pelvis. Int J Radiat Oncol Biol Phys. 1988;15:809-813.
40. Calvin DP, Connell PP, Rotmensch J, et al. Surgery and postoperative radiation therapy in stage II endometrial carcinoma. Am J Clin Oncol. 1999;22:338-343.
41. Weiss E, Hirnle P, Arnold-Bofinger H, et al. Therapeutic outcome and relation of acute and late side effects in the adjuvant radiotherapy of endometrial carcinoma stage I and II. Radiother Oncol. 1999;53:37-44.
42. Pignon T, Horiot JC, Bolla M, et al. Age is not a limiting factor for radical radiotherapy in pelvic malignancies. Radiother Oncol. 1997;42:107-120.
43. Zachariah B, Balducci L, Venkattaramanabalaji GV, et al. Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side effects. Int J Radiat Oncol Biol Phys. 1997;39:1125-1129.
44. Huguenin P, Baumert B, Lutolf UM, et al. Curative radiotherapy in elderly patients with endometrial cancer. Patterns of relapse, toxicity and quality of life. Strahlenther Onkol. 1999;175:309-314.
45. Alektiar KM, Venkatraman E, Abu-Rustum N, et al. Is endometrial carcinoma intrinsically more aggressive in elderly patients? Cancer. 2003;98:2368-2377.
46. Firat S, Byhardt RW, Gore E. Comorbidity and Karnofsky performance status are independent prognostic factors in stage III non small cell lung cancer. An institutional analysis of patients treated on four RTOG studies. Int J Radiat Oncol Biol Phys. 2002;54:357-364.
47. Wells CK, Stoller JK, Feinstein AR, et al. Comorbid and clinical determinants of prognosis in endometrial cancer. Arch Intern Med. 1984;144:2004-2009.